High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer

• Published in: Pathology oncology research Vol. 28; p. 1610315
• Main Authors: Polk, Nándor, Budai, Barna, Hitre, Erika, Patócs, Attila, Mersich, Tamás
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 27.04.2022
• Subjects: liver-only metastases of colon cancer; liver-only metastases of rectal cancer; metastasectomy; neutrophil-to-lymphocyte ratio; Pathology and Oncology Archive; relapse-free survival; systemic immune-inflammation index; relapse-free survival; systemic immune-inflammation index; neutrophil-to-lymphocyte ratio; metastasectomy; preoperative treatment; liver-only metastases of rectal cancer; liver-only metastases of colon cancer
• ISSN: 1532-2807; 1219-4956; 1532-2807
• DOI: 10.3389/pore.2022.1610315

The literature data regarding colon cancer patients with liver-only metastases (CLM) show that NLR determined before metastasectomy is a prognostic marker of shorter relapse-free survival (RFS), but no results has been reported to date for rectal cancer patients with liver-only metastases (RLM). This study aimed to investigate the NLR and SII in CLM and RLM. Relapse-free (RFS) and overall survival (OS) were evaluated in 67 CLM and 103 RLM patients with a median follow-up of 46.5 and 59.8 months, respectively. Pre- and/or postoperative chemotherapy ± targeted treatment was applied in 96% and 87% of CLM and RLM patients, respectively. The cut-off level for hematologic parameters were determined by receiver operating characteristic (ROC) analysis. Univariate analysis was performed by Kaplan-Meier method and log rank test. For multivariate analysis Cox regression was applied. In univariate analysis low NLR (cut-off 2) and SII (535) were predictors of longer RFS in case of CLM ( < 0.01). In contrast, for RLM high NLR (2.42) and SII (792) were predictors of longer RFS ( < 0.001). For RLM both NLR and SII proved to be independent markers of RFS (HR 0.66 (95% CI 0.52-0.84) and 0.73 (0.57-0.91), respectively) and OS (0.76 (0.58-0.99) and 0.66 (0.5-0.87), respectively). Only NLR (1.44 (1.04-1.99)) was independent marker of RFS for CLM. The preoperative treatment has not influenced the role of NLR or SII. In contrast to CLM, in RLM the high NLR or SII determined before metastasectomy proved to be independent prognostic factors of longer RFS and OS.